Schizophrenia-like GABAergic gene expression deficits in cerebellar Golgi cells from rats chronically exposed to low-dose phencyclidine
about
GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for SchizophreniaMolecular substrates of schizophrenia: homeostatic signaling to connectivityImpaired limbic cortico-striatal structure and sustained visual attention in a rodent model of schizophrenia.Animal models of schizophrenia.Abnormalities of neuronal oscillations and temporal integration to low- and high-frequency auditory stimulation in schizophreniaModulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives.mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.Opposite effects of acute ethanol exposure on GAP-43 and BDNF expression in the hippocampus versus the cerebellum of juvenile rats.Increased expression of axogenesis-related genes and mossy fibre length in dentate granule cells from adult HuD overexpressor mice.Role of glutamic acid decarboxylase 67 in regulating cortical parvalbumin and GABA membrane transporter 1 expression: implications for schizophreniaThe inhibitory GABA system as a therapeutic target for cognitive symptoms in schizophrenia: investigational agents in the pipeline.The role of the cerebellum in schizophrenia: from cognition to molecular pathways.Leading compounds for the validation of animal models of psychopathology.The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia.Exogenous Sonic hedgehog modulates the pool of GABAergic interneurons during cerebellar development.Neuronal RNA-binding protein HuD regulates addiction-related gene expression and behavior.Genetic and animal model analyses reveal the pathogenic role of a novel deletion of RELN in schizophrenia
P2860
Q30362301-7175AF69-A8DF-45C6-9AF2-5A160BDE002AQ30383611-77197569-C98E-4CD2-82C4-DC9B9F4A3001Q30403790-A5D1E13E-F141-4683-9DFA-5D646DC8B536Q30462828-B2AAB283-82F0-44A7-AB8B-4DCF0B5D0A61Q30467569-D67BA2B3-E400-485A-AC47-CE4627829FEEQ33659830-27AA6CF1-EF13-43BB-A937-D0B09A9C3B6CQ34513221-202165ED-5A6B-487A-B496-F0EE200BBDE7Q35059020-11E6FF96-42F8-4862-B9D8-6F3C81ABB5A5Q35602404-EC142E2F-D573-40AE-8DE7-03EBB52AF04CQ36501678-564FA2EC-DC5D-44EE-AF7C-B8C69410A20AQ37784829-797C4510-9480-4F5D-A4C4-2C8E115C903FQ37903740-6A53F8EF-5364-4974-87DF-C9B950C13BDFQ38128733-B87EFD66-CEA6-46D3-B516-1BBDD464C08DQ38526546-DD09A8A5-D943-4C14-BD71-C0A8EFD2BE03Q43604036-23BC6044-CE5D-4FE7-A62E-47A760331259Q47249759-7D5EB8D0-E142-412F-B11F-C7DDC25877CDQ58695557-5DA48722-6997-4D94-9EA7-0B99F9ADCF9F
P2860
Schizophrenia-like GABAergic gene expression deficits in cerebellar Golgi cells from rats chronically exposed to low-dose phencyclidine
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Schizophrenia-like GABAergic g ...... osed to low-dose phencyclidine
@en
Schizophrenia-like GABAergic g ...... sed to low-dose phencyclidine.
@nl
type
label
Schizophrenia-like GABAergic g ...... osed to low-dose phencyclidine
@en
Schizophrenia-like GABAergic g ...... sed to low-dose phencyclidine.
@nl
prefLabel
Schizophrenia-like GABAergic g ...... osed to low-dose phencyclidine
@en
Schizophrenia-like GABAergic g ...... sed to low-dose phencyclidine.
@nl
P2093
P2860
P1476
Schizophrenia-like GABAergic g ...... osed to low-dose phencyclidine
@en
P2093
C Fernando Valenzuela
Federico Bolognani
Nora I Perrone-Bizzozero
Paolo Botta
W Michael Bullock
P2860
P304
P356
10.1016/J.NEUINT.2009.07.010
P577
2009-08-03T00:00:00Z